Pediatric Measles Vaccine with Dengue Antigen
Author Information
Author(s): Brandler Samantha, Lucas-Hourani Marianne, Moris Arnaud, Frenkiel Marie-Pascale, Combredet Chantal, Février Michèle, Bedouelle Hugues, Schwartz Olivier, Desprès Philippe, Tangy Frédéric
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
Can a measles vaccine expressing a dengue antigen induce long-lasting immunity against dengue virus?
Conclusion
The study found that the measles vaccine expressing a dengue antigen successfully induced durable, serotype-specific neutralizing antibodies against dengue virus in mice.
Supporting Evidence
- The vaccine induced long-term production of dengue virus serotype-specific neutralizing antibodies in mice.
- The presence of the ectodomain of the membrane protein was critical for the immunogenicity of the dengue antigen.
- Immunization with the vaccine resulted in a significant increase in cytokine and chemokine secretion from dendritic cells.
Takeaway
Researchers created a new vaccine that combines measles and dengue protection, and it worked well in mice, making it a promising option for kids in areas where both diseases are common.
Methodology
The study involved immunizing genetically modified mice with a recombinant measles vaccine expressing a dengue antigen and measuring the resulting antibody responses.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Genetically modified CD46-IFNAR mice, susceptible to measles virus infection.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website